Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS

Go back to Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS
(NASDAQ: COYA) Delayed: 5.86 +0.20 (3.53%)
Previous Close $5.66    52 Week High
Open $5.75    52 Week Low
Day High $6.10    P/E N/A 
Day Low $5.57    EPS
Volume 107,486